ARTICLE | Finance
CAR T play Legend looks to lead trio of biotechs onto NASDAQ
Pliant, Lantern also hope to price IPOs this week
June 2, 2020 3:00 AM UTC
Look for three biotechs to price IPOs on NASDAQ this week, with CAR T company Legend the headliner.
The Nanjing-based company, which is spinning out of GenScript Biotech Corp. (HKSE:1548), aims to raise $350 million in an offering on NASDAQ that, if priced at the mid-point of its $18-$20 price range, would value the company at $2.5 billion. The deal is expected to price on Friday...